Financial Gravity Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-53
Closed -$3.75K 1766
2024
Q1
$3.75K Buy
53
+47
+783% +$2.97K ﹤0.01% 934
2023
Q4
$458 Buy
6
+3
+100% +$197 ﹤0.01% 1167
2023
Q3
$203 Sell
3
-91
-97% -$7.72K ﹤0.01% 949
2023
Q2
$9.25K Buy
+94
New +$7.33K 0.03% 357
2023
Q1
Sell
-50
Closed -$38 1309
2022
Q4
$38 Buy
+50
New +$2.04K ﹤0.01% 1253
2020
Q2
Sell
-3
Closed -$149 298
2020
Q1
$149 Buy
+3
New +$244 ﹤0.01% 808

Other funds holding EXAS

Financial Gravity Asset Management's EXAS Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 53 shares — an estimated $3.75K sold.

Financial Gravity Asset Management first reported a position in EXAS in Q1 2020 and held it in 6 quarters. The position peaked at $9.25K in Q2 2023. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 53 Exact Sciences shares in Q2 2024, an estimated $3.75K.
  • Financial Gravity Asset Management first reported a position in Exact Sciences in Q1 2020 and held it in 6 quarters.
  • Financial Gravity Asset Management's Exact Sciences position peaked at $9.25K in Q2 2023.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.